PERI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 13.083
EU - Europa 9.724
AS - Asia 4.989
SA - Sud America 746
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 153
OC - Oceania 104
Totale 28.984
Nazione #
US - Stati Uniti d'America 12.864
PL - Polonia 3.065
RU - Federazione Russa 2.423
IT - Italia 1.571
SG - Singapore 1.364
CN - Cina 1.162
HK - Hong Kong 708
VN - Vietnam 610
SE - Svezia 587
BR - Brasile 578
IE - Irlanda 572
KR - Corea 439
DE - Germania 346
FI - Finlandia 254
UA - Ucraina 217
FR - Francia 216
IN - India 193
GB - Regno Unito 156
CA - Canada 136
CH - Svizzera 124
AU - Australia 98
BD - Bangladesh 97
ID - Indonesia 79
JO - Giordania 76
AR - Argentina 60
TR - Turchia 59
NL - Olanda 41
JP - Giappone 40
MX - Messico 35
RO - Romania 33
AT - Austria 31
IQ - Iraq 31
EC - Ecuador 28
CI - Costa d'Avorio 24
ZA - Sudafrica 24
CO - Colombia 21
ES - Italia 21
BE - Belgio 19
NG - Nigeria 17
PH - Filippine 16
CL - Cile 15
VE - Venezuela 15
MA - Marocco 14
UZ - Uzbekistan 13
IL - Israele 11
KE - Kenya 11
PY - Paraguay 11
NP - Nepal 10
PK - Pakistan 10
EG - Egitto 9
SA - Arabia Saudita 9
SC - Seychelles 9
AL - Albania 8
HN - Honduras 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
UY - Uruguay 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IR - Iran 6
JM - Giamaica 6
LT - Lituania 6
NZ - Nuova Zelanda 6
TN - Tunisia 6
CM - Camerun 5
CR - Costa Rica 5
GE - Georgia 5
GT - Guatemala 5
MU - Mauritius 5
MY - Malesia 5
SV - El Salvador 5
DK - Danimarca 4
DZ - Algeria 4
GR - Grecia 4
MG - Madagascar 4
SN - Senegal 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
BJ - Benin 3
EU - Europa 3
KZ - Kazakistan 3
LV - Lettonia 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CG - Congo 2
ET - Etiopia 2
GD - Grenada 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
Totale 28.768
Città #
Warsaw 3.061
Santa Clara 2.043
Ashburn 1.550
Fairfield 1.188
Singapore 1.000
Chandler 601
Dublin 571
Hong Kong 567
Woodbridge 534
Seattle 485
Cambridge 468
San Jose 428
Houston 423
Seoul 398
Jacksonville 392
Wilmington 386
Milan 323
Beijing 294
Council Bluffs 281
Ann Arbor 230
Hefei 205
Los Angeles 196
Ho Chi Minh City 192
Lawrence 190
Altamura 183
Princeton 160
Florence 158
The Dalles 158
Hanoi 150
Lauterbourg 138
Dallas 132
Buffalo 123
Boston 120
Rome 118
Boardman 117
New York 116
Bern 114
Moscow 104
Munich 100
Mumbai 99
Melbourne 92
Helsinki 82
San Diego 76
Medford 67
Shanghai 67
São Paulo 62
Phoenix 60
Jakarta 57
Dong Ket 44
Naples 42
London 37
Toronto 35
Izmir 32
Da Nang 31
Paris 31
Chicago 30
Kent 30
Turin 30
Figino 29
Turku 29
Timisoara 28
Bologna 27
Clifton 27
Vienna 27
Brooklyn 26
Pune 26
Redondo Beach 26
Tokyo 26
West Jordan 26
Falls Church 25
Seongnam 25
Abidjan 24
Frankfurt am Main 24
Norwalk 24
Columbus 23
Bari 21
Rio de Janeiro 21
Verona 21
Atlanta 19
Haiphong 19
Montreal 19
Guangzhou 18
Tianjin 18
Brussels 17
Orem 17
Chennai 16
Lappeenranta 16
Abuja 15
Auburn Hills 15
Palermo 15
Belo Horizonte 14
San Francisco 14
Yubileyny 14
Baghdad 13
Barcelona 13
Denver 13
Curitiba 12
Genoa 12
Brescia 11
Johannesburg 11
Totale 19.837
Nome #
Gonadotropin-releasing hormone modulates cholesterol synthesis and steroidogenesis in SH-SY5Y cells. 405
Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1 401
Exendin-4 induces cell adhesion and differentiation and counteracts the invasive potential of human neuroblastoma cells. 383
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. 374
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor 357
Relationship between the neuroprotective effects of Insulin-Like Growth Factor-1 and 17β-Oestradiol in human neuroblasts. 347
Neurohypophyseal hormone regulation of endothelin secretion from rabbit endometrial cells in primary culture. 346
Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? 343
Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures 341
Seladin-1/dhcr24 protects neuroblastoma cells against aβ toxicity by increasing membrane cholesterol content 338
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 328
Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. 315
A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum 305
UTEROGLOBIN AND TRANSGLUTAMINASE MODULATE HUMAN SPERM FUNCTIONS. 305
Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis 296
A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans 293
Current Treatment Practice and Outcomes. Report of the Hyponatremia Registry. 286
THE EFFECTS OF AN AUTOCRINE LOOP MEDIATED BY PLATELET-ACTIVATING FACTOR (PAF) IN HEC-1A CELLS ARE REVERTED BY UTEROGLOBIN. 284
Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness. 280
PPARgamma in Neuroblastoma. 279
The use of vaptans in clinical endocrinology 277
Correction: Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis 262
A case of malignant insulinoma responsive to somatostatin analogs treatment 255
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 242
Prognostic and predictive role of hyponatremia in cancer patients 241
Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model. 240
A unique neuroendocrine cell model derived from the human foetal neural crest. 239
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. 223
Hyponatremia and Cancer: From Bedside to Benchside 221
The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis 220
A case of hyponatremia caused by central hypocortisolism 218
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 214
Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. 212
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases 210
Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1) 210
Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: a novel mechanism for chronic hyponatremia-induced bone loss 205
Hyponatremia, IL‑6, and SARS‑CoV‑2 (COVID‑19) infection: may all fit together? 204
Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. 201
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. 201
Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia. 201
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 201
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. 199
Hyponatremia alters the biophysical properties of neuronal cells independently of osmolarity: a study on Ni(2+) -sensitive current involvement 199
Adrenal incidentaloma: the influence of a decision-making algorithm on the short-term outcome of laparoscopy 196
Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis 194
Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas. 194
ENDOTHELIN IN THE HUMAN UTERUS DURING PREGNANCY. 194
Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells 193
Neuronal differentiation of human mesenchymal stromal cells increases their resistance to Aβ42 aggregate toxicity. 192
IMMUNOLOCALIZATION, BINDING, AND BIOLOGICAL ACTIVITY OF ENDOTHELIN IN RABBIT UTERUS: EFFECT OF OVARIAN STEROIDS. 191
Hormonal modulation of cholesterol: experimental evidence and possible translational impact 190
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 188
SPECIFIC FEATURES OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS OVER 70 YEARS OF AGE. 186
Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection 186
ENDOTHELIN IN RABBIT UTERUS DURING PREGNANCY. 185
Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models. 184
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. 181
Sindrome di Hoffmann in un caso di severo ipotiroidismo 181
Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer 181
Hyponatraemia 180
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma 179
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: Impact on patient outcome 179
Analysis of somatostatin receptor 2 and 5 polymorphisms in patients with acromegaly. 177
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 177
The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells 176
Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours. 175
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. 175
GENE EXPRESSION OF ENDOTHELIN-1, ENDOTHELIN-CONVERTING ENZYME-1, AND ENDOTHELIN RECEPTORS IN HUMAN EPIDIDYMIS 173
New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. 171
Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro 170
Erectile Dysfunction is Common among Men with Acromegaly and is Associated with Morbidities Related to the Disease. 170
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. 169
Endothelin-1 is synthesized and biologically active in human epididymis via a paracrine mode of action. 169
The Yin and Yang Effect of the Apelinergic System in Oxidative Stress 168
In vivo effects of rosiglitazone in a human neuroblastoma xenograft 168
Mechanisms for neuroprotective effects of estrogens: the role of cholesterol 166
Steroid modulation of oxytocin/vasopressin receptors in the uterus 164
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 163
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 163
Predictors of morbidity and mortality in acromegaly: an Italian survey. 163
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. 163
Estrogen and Selective Estrogen Receptor Modulators exert neuroprotective effects and stimulate the expression of seladin-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell cultures. 162
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene. 162
High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow. 160
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. 159
Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study. 158
Neuronal distress induced by low extracellular sodium in vitro is partially reverted by the return to normal sodium 157
Hyponatremia, falls and bone fractures: A systematic review and meta-analysis 155
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 155
Hyponatremia and pituitary adenoma: think twice about the etiopathogenesis. 154
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 154
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. 153
Identification, characterization, and biological activity of endothelin receptors in human ovary. 153
Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. 152
Expression of the anti-apoptotic gene seladin-1 and octreotide-induced apoptosis in GH-secreting and in non-functioning pituitary adenomas. 152
Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage 151
Considerations regarding the management of hyponatraemia secondary to SIADH 151
Cyclic adenosine 3',5'-monophosphate Responsive Element Modulator gene expression in germ cells of normo- and oligoazoospermic men 150
Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. 150
Characterizing an ectopic secreting carcinoid with indium-111-DTPA-D-Phe-pentetreotide. 149
Totale 21.412
Categoria #
all - tutte 79.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022919 0 0 81 38 24 56 39 75 54 73 194 285
2022/20232.765 261 548 108 202 207 464 347 119 262 30 74 143
2023/20241.035 40 99 159 51 76 160 31 230 20 79 42 48
2024/20256.340 247 723 432 1.016 1.813 739 86 264 367 181 258 214
2025/20268.221 872 1.086 645 674 773 300 1.041 406 478 519 290 1.137
2026/2027994 376 474 144 0 0 0 0 0 0 0 0 0
Totale 28.984